.Bicara Therapeutics and also Zenas Biopharma have actually provided fresh catalyst to the IPO marke...
.Genentech will definitely close its cancer immunology study division, as well as device mind and al...
.Kezar Lifestyle Sciences is falling its dim stage 1 solid tumor drug as the biotech goes all-in on ...
.Regardless of izokibep keeping its own newfound winning touch in the center, Acelyrin is no longer ...
.Rivus Pharmaceuticals has actually plumped up the customers of its own fat-busting, muscle-sparing ...
.Ovid Therapy already disclosed last month that it was trimming back its head count as the business ...
.Eli Lilly has actually opened a $700 million R&D center in the Boston ma Seaport, boosting its o...
.Just five months after securing a $100 thousand IPO, Boundless Biography is actually laying off som...
.The first stages of oncology R&D may not be short of interesting new methods, and Halda Therapie...
.Psychopharmacology has taken three posts concerning midstage medical test data assessing Lykos Reha...